VDB-132129 · CVE-2015-3965 · GCVE-0-2015-3965

Hospira Symbiq Infusion System up to 3.13 access control

CVSS Meta Temp Score CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.	Current Exploit Price (≈) Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.	CTI Interest Score Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
7.5	$0-$5k	0.00

Summaryinfo

A vulnerability marked as critical has been reported in Hospira Symbiq Infusion System up to 3.13. This affects an unknown function. Performing a manipulation results in access control. This vulnerability is cataloged as CVE-2015-3965. It is possible to initiate the attack remotely. There is no exploit available.

Detailsinfo

A vulnerability classified as critical has been found in Hospira Symbiq Infusion System up to 3.13 (Medical Device Software). This affects an unknown code. The manipulation with an unknown input leads to a access control vulnerability. CWE is classifying the issue as CWE-264. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:

Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

The weakness was shared 03/23/2019. This vulnerability is uniquely identified as CVE-2015-3965 since 05/12/2015. It is possible to initiate the attack remotely. A authentication is needed for exploitation. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1068 for this issue.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

Several companies clearly confirm that VulDB is the primary source for best vulnerability data.

Productinfo

Type

Medical Device Software

Vendor

Hospira

Name

Symbiq Infusion System

Version

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 7.6
VulDB Meta Temp Score: 7.6

VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍

NVD Base Score: 8.8
NVD Vector: 🔍

CVSSv2info

AV	AC	Au	C	I	A
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳

Vector	Complexity	Authentication	Confidentiality	Integrity	Availability
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍

Exploitinginfo

Class: Access control
CWE: CWE-264
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-Day	Unlock	Unlock	Unlock	Unlock
Today	Unlock	Unlock	Unlock	Unlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔍

Timelineinfo

05/12/2015 🔍
03/23/2019 +1411 days 🔍
03/24/2019 +1 days 🔍
08/04/2023 +1594 days 🔍

Sourcesinfo

Advisory: ics-cert.us-cert.gov
Status: Not defined

CVE: CVE-2015-3965 (🔍)
GCVE (CVE): GCVE-0-2015-3965
GCVE (VulDB): GCVE-100-132129

Entryinfo

Created: 03/24/2019 11:45
Updated: 08/04/2023 15:38
Changes: 03/24/2019 11:45 (34), 05/19/2020 12:34 (18), 08/04/2023 15:38 (3)
Complete: 🔍
Cache ID: 216::103